Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium Carbonate Following Stroke
NCT01112813Phase 3Completed
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Apr 2010
- Primary completion
- Jul 2017
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of lithium carbonate in stroke, sponsored by Sunnybrook Health Sciences Centre. Primary endpoint: Increase in total brain gray matter volumes at 2 months. Started Apr 2010; status: completed.
02
Drugs
lithium carbonate
03
Conditions
stroke
Beyond the preview
Go deeper on NCT01112813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01112813.